Form 4: Genelux Corp Executive Ralph Smalling Reports Transaction
SEC Form 4
Ralph Smalling, Head of Regulatory at Genelux Corp, reports the acquisition and disposal of common stock and warrants.
Summary
- On May 29, 2024, Ralph Smalling, Head of Regulatory at Genelux Corporation, reported a transaction involving the company's securities.
- Smalling acquired 1,250 shares of common stock.
- Smalling disposed of 13,315 shares of common stock.
- Smalling also acquired 1,250 common stock warrants with an exercise price of $5.25, exercisable from May 29, 2024, to May 29, 2029.
- The shares and warrants were sold together at a combined price of $4.00 per share and warrant.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect broader industry trends but offers insight into the actions of a key executive at Genelux Corp.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership reported by an officer of the company.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction involving common stock and warrants. |
| 05/29/2024 | Warrants become exercisable. |
| 05/29/2029 | Warrants expire. |
| 06/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.